Internal review finds the American Diabetes Association did not remove members from its New Orleans event because of the content of an editorial, concluding instead that their conduct—handing out printed material in restricted areas—prompted the expulsions. Five participants were ejected after distributing a commentary that criticized federal research funding; that piece ran in Diabetes Care on April 29 and was handed out outside the session where the National Institutes of Health director was scheduled to speak. The editorial is available at Diabetes Care.
The findings come from a five-person committee convened by the association and are summarized in a press statement that the organization released Tuesday; the full text of that release is online at American Diabetes Association. The committee says its inquiry determined the decision to remove attendees was motivated by breaches of conference rules governing distribution of materials in designated areas, rather than by disagreement with the commentary’s arguments about federal funding.
The report specifically rejects assertions that the association’s action constituted a censorship of dissenting views or that it involved summoning local law enforcement. The panel referenced existing event policies that limit where printed items may be handed out; those policies are posted in the ADA conference guidance. The expulsions occurred during the association’s scientific sessions in early June and have continued to attract attention from members and observers concerned about how professional gatherings handle protests and printed advocacy.
The committee forwarded its conclusions to the ADA board for consideration of any follow-up measures. The episode highlights tensions that can arise when societies enforce conduct rules while also managing forums for debate; it may prompt organizations to clarify distribution policies and enforcement practices at future meetings. Coverage and commentary around the case continue, including public reaction from attendees at the New Orleans conference and ongoing discussion within the diabetes community and broader academic societies, as reflected in post-event statements and coverage.
